Peptide / Unit conversion

GHK-Cu reconstitution calculator

Enter your GHK-Cu vial size, the volume of liquid added and the dose to calculate concentration and syringe units.

Your inputs determine the result. This calculator does not recommend dosages.

Live readout

Set your draw.

Enter your vial strength, diluent, and dose to see the draw.

Mode
Resulting concentration -- mg/mL
Doses per vial --
Syringe

Conversion follows standard mg, mL, and U-100 syringe references.

Performs unit conversions only. Not medical advice. Consult your healthcare provider.

Save preset

After saving, open Presets at the top of the calculator to recall this setup.

Saved presets

No saved presets

Save a conversion from the calculator to recall it later.

    Units chart

    GHK-Cu units chart (mg to U-100 units)

    GHK-Cu units chart: mg to U-100 units

    The tables use 50 mg as an example vial size (input); no source is cited for that size. Its profile describes a naturally occurring copper tripeptide.

    Vial concentration

    Water mL is treated as final solution mL in these columns.

    GHK-Cu: concentration in mg per mL
    Vial contents1 mL water2 mL water3 mL water
    50 mg50 mg/mL2 U-100 units per mg25 mg/mL4 U-100 units per mg16.6667 mg/mL6 U-100 units per mg

    Example vial size (input): 50 mg. No source is cited for this size; it is an arithmetic input, not a sourced fact.

    Amount to units

    Example amounts (arithmetic only, not doses).

    GHK-Cu: amount to U-100 syringe units
    Amount (mg)50 mg + 1 mL50 mg + 2 mL50 mg + 3 mL
    1 mg2 units4 units6 units
    2.5 mg5 units10 units15 units
    5 mg10 units20 units30 units
    10 mg20 units40 units60 units
    25 mg50 units100 units150 unitsover one syringe

    Cited amounts

    No human dose has been established. The amount table contains arithmetic examples only.

    How to read this chart

    units = amount ÷ (vial mg ÷ water mL) × 100

    The reconstitution calculator walks through each step, and units to mg converts between mg, mcg, mL and units.

    Topical literature and the systemic model

    PinPoint's GHK-Cu description distinguishes the better-described topical and endogenous-peptide literature from the less-characterized systemic injectable profile. Its pharmacology citation is classified as a peer-reviewed review. In that review, the human studies are topical creams and injection was studied only in animals.

    What a 50 mg example vial changes

    The example vial size (input) is 50 mg. At 1 mL the concentration is 50 mg per mL; at 2 mL it is 25 mg per mL. Those values are ten times the concentrations of a 5 mg vial represented at the same volumes. That comparison explains why borrowing a unit marking from a smaller peptide vial would produce a different mg amount. The vial's total contents are part of the conversion, even when both vials share the same liquid volume.

    The example rows for this larger vial

    The GHK-Cu amount table runs through 1, 2.5, 5, 10, and 25 mg. Each value is calculated from the 50 mg total rather than copied from a preset list. At 25 mg per mL, the 2.5 mg example is 0.1 mL, while the 10 mg example is 0.4 mL. Their U-100 equivalents are 10 and 40 units. The syringe-unit figures come from this website's arithmetic on the example vial. Separately, the app logs GHK-Cu in mg and places it in the peptide category.

    Another vial example

    How do you convert a 50 mg GHK-Cu vial to mL and units?

    Divided into a hypothetical 5 mL final volume, the 50 mg vial gives 10 mg/mL; each U-100 unit is then 0.1 mg, and 1 mg occupies 0.1 mL, or 10 units. Divided into 2 mL instead, it gives 25 mg/mL, where 1 mg is just 4 units, a short and hard-to-read distance on a syringe.

    The 1 mg row is a round fiftieth of the vial, chosen to show the scale.

    50 mg ÷ 5 mL = 10 mg/mL; 1 unit = 0.1 mg

    1 mg ÷ 10 mg/mL = 0.1 mL = 10 units

    50 mg ÷ 2 mL = 25 mg/mL; 1 mg = 4 units

    Arithmetic example, not a dose.

    Compound profile

    GHK-Cu at a glance

    GHK-Cu is a copper-binding tripeptide studied in cell, animal, and topical skin research.[1] The cited review reports no pharmacokinetic data and no study of injected GHK-Cu in people.

    Regulatory status
    GHK-Cu is not approved by FDA for any use (Drugs@FDA, checked 19 November 2026); FDA lists GHK-Cu for injectable routes among compounding substances whose nomination was withdrawn, noting that compounded injectable GHK-Cu may pose a risk of immunogenicity and that there are limited data in humans to inform safety.[2][3]
    Half-life
    No published half-life value exists for GHK-Cu in this form.
    Route
    Topical (human cosmetic studies); injection studied only in animals.[1]
    Category
    Peptide
    Vial size
    50 mg, example vial size (input)

    Evidence

    What the research says

    The cited review examines GHK and its copper complex in skin repair research. It brings together cell experiments, animal wound models, and topical human observations. Laboratory endpoints include collagen and glycosaminoglycan production, matrix-remodeling enzymes, fibroblast activity, and gene-expression changes rather than one common clinical outcome.[1]

    Animal studies discussed in the review include wound-healing experiments in rodents and other species. The human cosmetic literature concerns topical application and measurements such as skin density, firmness, and appearance. Those settings differ substantially from measuring the systemic disposition of an injected copper-peptide preparation.[1]

    The review supports the identity of GHK as a naturally occurring tripeptide with copper-binding properties. The review reports no half-life.[1]

    What does the research on GHK-Cu report?

    GHK is the tripeptide glycyl-L-histidyl-L-lysine, and GHK-Cu is its complex with a copper ion [1]. GHK occurs naturally in human plasma, saliva and urine, and its concentration in plasma falls with age, according to the cited review.

    The review describes placebo-controlled studies of GHK-Cu creams in women; it reports no study of injected GHK-Cu in people [1].

    None of this establishes an injectable amount for people. A review of mechanisms and topical cosmetics can say what GHK-Cu has been tested for; it cannot be read backward into a schedule for a subcutaneous vial.

    Timing

    Half-life and timing

    No published half-life value exists for GHK-Cu in this form.

    Calculator details

    About this calculation.

    What does GHK-Cu injection dosage research establish here?

    The one cited review does not establish a human injection amount; it says future research is needed to establish the effective dosage in humans. The page explains the 50 mg example vial (input) and its conversion arithmetic without presenting that total as a clinical dose.[1]

    Can a GHK-Cu dosage calculator bridge topical and injectable research?

    The calculator only manipulates entered units and volumes. It cannot establish that evidence for one route characterizes another. The human studies in the cited review are topical creams; injection appears only in animal studies.[1]

    Why is the 50 mg GHK-Cu example total shown at all?

    It gives the arithmetic example a concrete input. The figure is labeled as an example vial size (input) so its quantity is not mistaken for a human research amount. Readers can follow the arithmetic without treating the example as clinical evidence.

    What is GHK in GHK-Cu?

    GHK is the tripeptide glycyl-L-histidyl-L-lysine. GHK-Cu is that tripeptide bound to a copper ion. GHK occurs naturally in human plasma, and its level falls with age according to the cited review.[1]

    Does the topical GHK-Cu percentage convert to syringe units?

    No. Syringe-unit arithmetic applies only to a powder vial mixed with a known volume.

    What concentration is GHK-Cu at 50 mg in 1 mL?

    50 mg divided by 1 mL is 50 mg per mL. That volume spans 100 U-100 syringe units.

    How does 2 mL change the concentration of this GHK-Cu vial?

    50 mg divided by 2 mL is 25 mg per mL, half the concentration in the 1 mL column.

    What does the 3 mL column mean for GHK-Cu?

    50 mg divided by 3 mL is approximately 16.6667 mg per mL. The full 3 mL volume corresponds to 300 U-100 units.

    How many units is 5 mg of GHK-Cu from this vial in 2 mL?

    5 mg divided by 25 mg per mL is 0.2 mL, or 20 U-100 units.

    References

    Sources

    Sources checked against the cited documents on 19 November 2026.

    1. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration, review, 2015 (PMC4508379)Full text read 19 November 2026.Retrieved 2026-11-19 · review
    2. Drugs@FDA (openFDA), search for GHK, copper peptide and prezatide copperNo matches found (dataset last updated 18 November 2026).Retrieved 2026-11-19 · regulator
    3. FDA, certain bulk drug substances for use in compounding that may present significant safety risksContent current as of 22 April 2026; read on 19 November 2026.Retrieved 2026-11-19 · regulator
    4. PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description

    From the same library

    Related calculators

    Keep your protocol together

    Track the result in the app.

    Set up vials, log doses and sites, and see your next reminder in PinPoint for iOS.

    Download on the App Store
    Syringe readout: 10 units is 0.10 mL on a U-100 insulin syringe
    THE ARITHMETIC / 0.10 mL = 10 UNITS

    Keep exploring

    More tools

    PinPoint app icon

    Your next chapter starts here

    Start Day 1 with
    your numbers in place.

    Your doses, your schedule, your picture. Bring it together in PinPoint.

    Built for iPhone.

    Subscription through the App Store, cancel anytime in your Apple ID settings.